Advertisements



Provention CEO says creating new pharmaceutical category for autoimmunity

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Takeda clears key hurdle as investors back $59 billion Shire deal

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

$59bln: What it costs to become a drugs player

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Julian Satterthwaite reports......»»

Category: videoSource: reutersDec 5th, 2018

Takeda investors back $59 billion Shire deal, but wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

Takeda shareholders give nod for $59 billion Shire acquisition

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

Takeda shareholders approve Shire acquisition: spokesman

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

Oscars to Add ‘Popular Film’ Category, Creating Questions

By adding a new category, the Academy Awards risk signaling that blockbuster films are not worthy of consideration for the best overall picture honor......»»

Category: mediaSource: nytAug 8th, 2018

Here is What Hedge Funds Think About BioMarin Pharmaceutical Inc. (BMRN)

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quar.....»»

Category: topSource: insidermonkey4 hr. 57 min. ago

Major Health Care Catalysts Coming by the End of 2018

24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018......»»

Category: blogSource: 247wallstDec 8th, 2018

US-China trade truce creating investor agita, but America"s future is optimistic

Markets should set aside this short-term uncertainty and focus on the USA......»»

Category: topSource: foxnewsDec 7th, 2018

Tight Labor Market Creating Big Problems for Small Business

Finding labor may stop some companies from growing......»»

Category: topSource: foxnewsDec 7th, 2018

Congress to Drug Makers: Why Stock Buybacks Over Lowered Drug Prices?

House Democrats say big pharmaceutical companies channeled tax savings to repurchasing shares instead of making some medicines more affordable......»»

Category: smallbizSource: wsjDec 7th, 2018

Creating a Flexible Brokerage for Tomorrow’s Leaders

Creating a Flexible Brokerage for Tomorrow’s Leaders.....»»

Category: realestateSource: rismediaDec 6th, 2018

BioPharmX Reports Third Quarter 2019 Financial Results

MENLO PARK, Calif., Dec. 6, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE:BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results f.....»»

Category: earningsSource: benzingaDec 6th, 2018

Is Teva Pharmaceutical Industries Limited (TEVA) A Good Stock To Buy?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bul.....»»

Category: topSource: insidermonkeyDec 6th, 2018

Rising interest rates creating headaches for small businesses

As re-appraisals drop, businesses should consider SBA-backed loans as a way out.....»»

Category: topSource: moneycentralDec 6th, 2018

Infant Ibuprofen Recalled From Walmart, CVS, Family Dollar Over Fears of High Dosage

Tris Pharma, Inc. issued a recall on three lots of infant ibuprofen. The New Jersey pharmaceutical company Tris Pharma, Inc. has issued a recall on three l.....»»

Category: europeSource: fortuneDec 6th, 2018

Pharmaceutical (PPH) Shares Cross Below 200 DMA

Dividend Channel.....»»

Category: topSource: redinewsDec 6th, 2018

Pot purveyor lights the way for a new category of weed marketing

Cannabis retailer MedMen has been leading the charge to bring marijuana into the mainstream—a market estimated to hit $75 billion by 2030, says investment firm Cowen & Co. When recreational... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkDec 6th, 2018

CURE Pharmaceutical Readies $12 Million U.S. IPO

CURE Pharmaceutical Readies $12 Million U.S. IPO.....»»

Category: topSource: seekingalphaDec 6th, 2018

How People First honoree Catherine Masessa approaches inclusivity

Catherine Masessa Senior VP, human resources, LifeLink Foundation Inc. Creating an inclusive work culture where every staff member feels valued, accepted, treated fairly and respectfully is a paramount commitment in Catherine Masessa’s role a.....»»

Category: topSource: bizjournalsDec 6th, 2018